PAK2 and cancer: Coinciding with this notion, inspection of a publicly available database of large CRISPR-based genetic screens (DEPMAP/PICKLES [35, 36]) unveiled a clear association between sensitivity to loss of PAK2 and loss of its binding partner βPIX (ARHGEF7) across a large panel of pan-cancer cell lines.